Home
  • Study at Cambridge
  • About the University
  • Research at Cambridge
  • For Cambridge students
  • For staff
  • For alumni
  • For our researchers
  • Business and enterprise
  • Colleges and Departments
  • Give to Cambridge
  • Libraries
  • Museums and collections
  • Study at Cambridge
  • Undergraduate
    • Courses
    • Applying
    • Events and open days
    • Fees and finance
  • Postgraduate
    • Postgraduate courses
    • How to apply
    • Fees and funding
    • Postgraduate events
  • International students
  • Professional and continuing education
  • Executive and professional education
  • Courses in education
  • About the University
  • How the University and Colleges work
  • Term dates
  • History
  • Map
  • Visiting the University
  • News
  • A global university
  • Annual reports
  • Equality and diversity
  • Events
  • Public engagement
  • Jobs
  • Give to Cambridge
  • Research at Cambridge
  • For Cambridge students
  • For staff
  • For alumni
  • For our researchers
  • Business and enterprise
  • Colleges and Departments
  • Give to Cambridge
  • Libraries
  • Museums and collections
  • Home
  • Subjects
  • Articles about 'statins'

Articles about 'statins'

Mother is holding a tiny hand of her preterm baby that is in the NICU.

Combined steroid and statin treatment could reduce ‘accelerated ageing’ in preterm babies, study in rats suggests

02 February 2023

Potentially life-saving steroids commonly given to preterm babies also increase the risk of long-term cardiovascular problems, but a new study in rats has found that if given in conjunction with statins, their positive effects remain while the potential negative side-effects are ‘weeded out’.

Read More
Medications

Concerns over side effects of statins stopping stroke survivors taking medication

17 July 2017

Negative media coverage of the side effects associated with taking statins, and patients’ own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially life-saving drugs, according to research published today.

Read More
Fibrils of amyloid-beta

Researchers identify ‘neurostatin’ that may reduce the risk of Alzheimer’s disease

12 February 2016

An approved anti-cancer drug successfully targets the first step in the toxic chain reaction that leads to Alzheimer’s disease, suggesting that treatments may be found to lower the risk of developing the neurodegenerative condition.

Read More
Subscribe to statins

Connect with us

  • Facebook
  • Instagram
  • LinkedIn
  • X
  • YouTube
Cambridge University

© 2025 University of Cambridge

  • Contact the University
  • Accessibility statement
  • Freedom of information
  • Privacy policy and cookies
  • Statement on Modern Slavery
  • Terms and conditions
  • University A-Z

Study at Cambridge

  • Undergraduate
  • Postgraduate
  • Professional and continuing education
  • Executive and professional education
  • Courses in education

About the University

  • How the University and Colleges work
  • Give to Cambridge
  • Jobs
  • Maps
  • Visiting the University
  • Cambridge University Press & Assessment

Research at Cambridge

  • Research news
  • About research at Cambridge
  • Public engagement